Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

被引：0

作者：

Shohei Eto

Yoko Nukui

Miyuki Tsumura

Yu Nakagama

Kenichi Kashimada

Yoko Mizoguchi

Takanori Utsumi

Maki Taniguchi

Fumiaki Sakura

Kosuke Noma

Yusuke Yoshida

Shinichiro Ohshimo

Shintaro Nagashima

Keisuke Okamoto

Akifumi Endo

Kohsuke Imai

Hirokazu Kanegane

Hidenori Ohnishi

Shintaro Hirata

Eiji Sugiyama

Nobuaki Shime

Masanori Ito

Hiroki Ohge

Yasutoshi Kido

Paul Bastard

Jean-Laurent Casanova

Osamu Ohara

Junko Tanaka

Tomohiro Morio

Satoshi Okada

机构：

[1] Hiroshima University Graduate School of Biomedical and Health Science,Department of Pediatrics

[2] Tokyo Medical and Dental University Hospital,Department of Infection Control and Prevention

[3] Kyoto Prefectural University of Medicine,Department of Infection Control and Laboratory Medicine

[4] Osaka City University,Department of Parasitology, Graduate School of Medicine

[5] Tokyo Medical and Dental University,Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences

[6] Hiroshima University Hospital,Department of Clinical Immunology and Rheumatology

[7] Hiroshima University Graduate School of Biomedical and Health Science,Department of Emergency and Critical Care Medicine

[8] Hiroshima University Graduate School of Biomedical and Health Sciences,Department of Epidemiology Infectious Disease Control and Prevention

[9] Tokyo Medical and Dental University Hospital,Clinical Research Center

[10] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences

[11] Tokyo Medical and Dental University,Department of Child Health and Development

[12] Gifu University Graduate School of Medicine,Department of Pediatrics

[13] Emeritus Professor of Hiroshima University,Department of General Internal Medicine

[14] Hiroshima University Hospital,Department of Infectious Diseases

[15] Hiroshima University Hospital,Laboratory of Human Genetics of Infectious Diseases, Necker Branch

[16] INSERM U1163,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch

[17] Necker Hospital for Sick Children,Department of Applied Genomics

[18] University of Paris,undefined

[19] Imagine Institute,undefined

[20] The Rockefeller University,undefined

[21] Howard Hughes Medical Institute,undefined

[22] Kazusa DNA Research Institute,undefined

来源：

Journal of Clinical Immunology | 2022年 / 42卷

关键词：

COVID-19; Antibodies to type I IFNs; IFN-α2; IFN-ω; Neutralization assay; IFN-α2 concentration;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1360 / 1370

页数：10

共 50 条

[31] Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome
Achleitner, Martin
Mair, Nina K.
Daenhardt, Juliane
Kardashi, Romina
Puhan, Milo A.
Abela, Irene A.
Toepfner, Nicole
de With, Katja
Kanczkowski, Waldemar
Jarzebska, Natalia
Rodionov, Roman N.
Wolf, Christine
Lee-Kirsch, Min Ae
Steenblock, Charlotte
Hale, Benjamin G.
Bornstein, Stefan R.
OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (01):
[32] Downregulation of type III interferons in patients with severe COVID-19
Yosuke, Fukuda
Homma, Tetsuya
Inoue, Hideki
Onitsuka, Chisato
Ikeda, Hitoshi
Goto, Yuiko
Sato, Yoko
Kimura, Tomoyuki
Hirai, Kuniaki
Ohta, Shin
Yamamoto, Mayumi
Kusumoto, Sojiro
Suzuki, Shintaro
Tanaka, Akihiko
Sagara, Hironori
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4559 - 4563
[33] Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Bencze, Dora
Fekete, Tunde
Pazmandi, Kitti
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
[34] Dysregulated Interferon Response Underlying Severe COVID-19
Lopez, LeAnn
Sang, Peter C.
Tian, Yun
Sang, Yongming
VIRUSES-BASEL, 2020, 12 (12):
[35] The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity
Po-Ku Chen
Kai-Jieh Yeo
Shih-Hsin Chang
Tsai-Ling Liao
Chia-Hui Chou
Joung-Liang Lan
Ching-Kun Chang
Der-Yuan Chen
Virology Journal, 20
[36] The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity
Chen, Po-Ku
Yeo, Kai-Jieh
Chang, Shih-Hsin
Liao, Tsai-Ling
Chou, Chia-Hui
Lan, Joung-Liang
Chang, Ching-Kun
Chen, Der-Yuan
VIROLOGY JOURNAL, 2023, 20 (01)
[37] Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening
Sharif-Askari, Narjes Saheb
Sharif-Askari, Fatemeh Saheb
Bayram, Ola Salam
Hafezi, Shirin
Alsayed, Hawra Ali Hussain
Kasim, Fathima
Mdkhana, Bushra
Selvakumar, Balachandar
Alsafar, Habiba S.
Halwani, Rabih
HEART & LUNG, 2024, 66 : 31 - 36
[38] Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19
Sun, Yuting
Wang, Gang
Wang, Rongshuai
Ren, Liang
Yuan, Zilin
Liu, Yueping
Wu, Yuzhang
Chen, Rong
Chen, Yongwen
Diao, Bo
JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 72 (08)
[39] Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients
Ko, Jae-Hoon
Joo, Eun-Jeong
Park, Su-Jin
Baek, Jin Yang
Kim, Won Duk
Jee, Jaehwan
Kim, Chul Joong
Jeong, Chul
Kim, Yae-Jean
Shon, Hye Jin
Kang, Eun-Suk
Choi, Young Ki
Peck, Kyong Ran
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 13
[40] Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
de Prost, Nicolas
Bastard, Paul
Arrestier, Romain
Fourati, Slim
Mahevas, Mathieu
Burrel, Sonia
Dorgham, Karim
Gorochov, Guy
Tandjaoui-Lambiotte, Yacine
Azzaoui, Iname
Fernandes, Ignacio
Combes, Alain
Casanova, Jean-Laurent
Mekontso-Dessap, Armand
Luyt, Charles-Edouard
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (03) : 536 - 544

← 1 2 3 4 5 →